In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2

Journal of Cell Science

Volumn 112, Issue 23, 1999, Pages 4213-4221

  Ribatti, Domenico ^a   Leali, Daria ^b   Vacca, Angelo ^a   Giuliani, Roberta ^b   Gualandris, Anna ^b,d   Roncali, Luisa ^a   Nolli, Maria Luisa ^c   Presta, Marco ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Biosearch Italia   (Italy)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Chick embryo; Extracellular matrix; FGF; Fibrinolysis; Urokinase

Indexed keywords

BENZYLSULFONYL FLUORIDE; FIBROBLAST GROWTH FACTOR 2; PLASMIN; UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ALLANTOIS; ANIMALS; CELL ADHESION MOLECULES; CELL LINE; CHICK EMBRYO; CHORION; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; KINETICS; NEOVASCULARIZATION, PHYSIOLOGIC; TRANSFECTION; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 0033490113     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Astedt, B. and Tropé, C. (1980). Effect of tranexamic acid on progress of experimental tumours and on DNA synthesis. Experientia 36, 679-680.
2. Avery, R. L., Connor, T. B. and Farazdaghi, M. (1990). Systemic amiloride inhibits experimentally induced neovascularization. Arch. Ophtalmol. 108, 1474-1476.
3. Bacharach, E., Itin, A. and Keshet, E. (1992). In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc. Nat. Acad. Sci. USA 89, 10686-10690.
4. Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J. and Vlodavsky, I. (1989). Basic tibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 28, 1737-1743.
5. Basilico, C. and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Advan. Cancer Res. 59, 115-165.
6. Bastaki, M., Nelli, E. E., Dell'Era, P., Rusnati, M., Molinari-Tosatti, M. P., Parolini, S., Auerbach, R., Ruco, L. P., Possati, L. P. and Presta, M. (1997). Mouse endothelium and its response to basic fibroblast growth factor: a comparative study on different cell lines. Arterioscler. Thromb. Vascular Res. 17, 454-464.
7. Berman, M., Winthrop, S., Ausprunk, D., Rose, J., Langer, R. and Gage, J. (1982). Plasminogen activator (urokinase) causes vascularization of the cornea. Invest. Ophthalmol. Vis. Sci. 22, 191-199.
8. Behrendt, N., Ronne E. and Dano, K. (1993). Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin. J. Biol. Chem. 268, 5985-5989.
9. 3 for angiogenesis. Science 264, 569-571.
10. Bugge, T. H., Flick, M. J., Daugherty, C. C. and Degen, J. L. (1995). Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev. 9, 794-807.
11. Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A. and Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119, 629-641.
12. Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J. J., Collen, D. and Mulligan, R. C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-424.
13. Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Isacchi, A., Caccia, P., Bergonzoni, L. and Presta, M. (1993). Biochemical hases of the interaction of human fibroblast growth factor with glycosaminoglycans. Eur. J. Biochem. 214, 51-58.
14. Corasanti, J. G., Hobika, G. H. and Markus, G. (1982). Interference with dimethylhydrazine induction of colon tumors in mice by ε-aminocaproic acid. Science 216, 1020-1021.
15. Corti, A., Sarubbi, E., Soffientini, A., Nolli, M. L., Zanni, A., Galimberti, M., Parenti, E. and Cassani, G. (1989). Epitope mapping of the anti-urokinase monoclonal antibody 5B4 by isolated domains of urokinase. Thromb. Haemostas. 62, 934-939.
16. De Petro, G., Copeta, A. and Barlati, S. (1994). Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts. Exp. Cell Res. 213, 286-294.
17. DiMario, J., Buffinger, N., Yamada, S. and Strohman, R. C. (1989). Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244, 688-690.
18. Estreicher, A., Wohlwend, A., Belin, D., Schleuning, W. D. and Vassalli, J.-D. (1989). Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264, 1180-1189.
19. Falcone, D. J., McCaffrey, T. A., Haimovitz-Friedman, A., Vergilio, J.-A. and Nicholson, A. (1993). Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J. Biol. Chem. 268, 11951-11958.
20. Fibbi, G., Caldini, R., Chevanne, M., Pucci, M., Schiavone, N., Morbidelli, L., Parenti, A., Granger, H. J., Del Rosso, M. and Ziche, M. (1998). Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Lab. Invest. 78, 1109-1119.
21. Flaumenhaft, R., Moscatelli, D. and Rifkin, D. B. (1990). Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J. Cell Biol. 111, 1651-1659.
22. Folkman, J., Klagsbrun, M., Sasse, J., Wadzinsky, M., Ingber, D. and Vlodavsky, I. (1988). A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol. 130, 393-400.
23. Gospodarowicz, D. and Cheng, J. (1986). Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128, 175-184.
24. Gualandris, A. and Presta, M. (1995). Transcriptional and post-transcriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J. Cell. Physiol. 162, 400-409.
25. Gualandris, A., Conejo, T. L., Giunciuglio, D., Albini, A., Sabini, E., Rusnati, M., Dell'Era, P. and Presta, M. (1997). Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. Microvasc. Res. 53, 254-260.
26. Hageman, G. S., Kirchoff-Rempe, M. A., Lewis, G. P., Fisher, S. K. and Anderson, D. H. (1991). Sequestration of basic fibroblast growth factor in the primate retinal interphotoreceptor matrix. Proc. Nat. Acad. Sci. USA 88, 6706-6710.
27. Iruela-Arispe, M. L., Lane, T. F., Redmond, D., Reilly, M., Bolender, R. P., Kavanagh, T. J. and Sage, E. H. (1995). Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol. Biol. Cell 6, 327-343.
28. Johnson, D. E. and Williams, L. T. (1993). Structural and functional diversity in the FGF receptor multigene family Advan. Cancer Res. 60, 1-41.
29. Koolwijk, P., van Erck, M. G. M., de Vree, W. J. A., Vermeer, M. A., Weich, H. A., Hanemaaijer, R. and van Hinsbergh, V. W. M. (1996) Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J. Cell Biol. 132, 1177-1188.
30. Mandriota, S. J., Seghezzi, G., Vassalli, J-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P. and Pepper, M. (1995). Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270, 9709-9716.
31. Mignatti, P. (1993). The fibrinolytic system and angiogenesis. Fibrinolysis 7, 20-21.
32. Mignatti, P. and Rifkin, D. B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
33. Mignatti, P., Tauboi, R., Robbins, E. and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor. J. Cell Biol. 108, 671-682.
34. Mignatti, P., Mazzieri, R. and Rifkin, D. B. (1991). Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 113, 1193-1201.
35. Moscatelli, D. (1986). Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J. Cell. Biochem. 30, 19-29.
36. Moscatelli, D. and Rifkin, D. B. (1988). Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochem. Biophys. Acta 948, 67-85.
37. Nguyen, M., Shing, T. and Folkman, J. (1994). Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc. Res. 47, 31-40.
38. Oh, S. J., Jeltsch, M. M., Birkenhager, R., McCarthy, J. E., Weiche, H. A., Christ, B., Alitalo, K. and Wilting, J. (1997). VFGF and VBGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 188, 96-109.
39. Pepper, M. S., Ferrara, N., Orci, L. and Montesano, R. (1991). Vascular endothelial growth factor (VFGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902-906.
40. Pepper, M. S., Montisano, R., Mandriota, S., Orci, L. and Vassalli, J.-D. (1996). Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. Enzyme Protein 49, 138-162.
41. Presta, M., Maier, J. A. M., Rusnati, M. and Ragnotti, G. (1989). Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. J. Cell. Physiol. 140, 68-74.
42. Ribatti, D., Urbinati, C., Nico, B., Rusnati, M., Roncali, L. and Presta, M. (1995). Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane. Dev. Biol. 170, 39-49.
43. Ribatti, D., Gualandris, A., Bastaki, M., Vacca, A., Roncali, L. and Presta, M. (1997). A new model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane (CAM): the gelatin sponge/CAM assay. J. Vasc. Res. 34, 455-463.
44. Ribatti, D., Bertossi, M., Nico, B., Vacca, A., Ria, R., Riva, A., Roncali, L. and Presta, M. (1998). Role of the basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study. J. Submicrosc. Cytol. Pathol. 30, 127-136.
45. Rogelj, S., Klagsbrun, M., Atzmon, R., Kurokawa, M., Haimovitz, A., Fuks, Z. and Vlodavsky, I. (1989). Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC 12 cells. J. Cell Biol. 109, 823-831.
46. Rusnati, M. and Presta, M. (1996). Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Int. J. Clin. Lab. Res. 26, 15-23.
47. Rusnati, M., Urbinati, C. and Presta, M. (1993). Internalization of basic fibroblast growth factor (bPGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors. J. Cell. Physiol. 154, 152-161.
48. Sabapathy, K. T., Pepper, M. S., Keifer, F., Mohle-Steinlein, U., Tacchini-Cottier, F., Fetka, I., Breier, G., Risau, W., Carmeliet, P., Montesano, R. and Wagner, E. F. (1997). Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system. J. Cell Biol. 137, 953-963.
49. Saksela, O. and Rifkin, D. B. (1988). Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
50. Saksela, O. and Rifkin, D. B. (1990). Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 110, 767-775.
51. Salonen, E.-M., Tervo, T., Torma, F., Tarkkanen, A. and Vaheri, A. (1987). Plasmin in tear fluid of patients with chronic ulcers. Basis for new therapy. Acta Ophthalmol. 65, 17-24.
52. Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K. and Takigawa, M. (1996). Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137, 3729-3737.
53. Teuscher, E. and Pester, E. (1984). A possible explanation of mechanisms inducing inhibition of vascularization of tumours by antifbrinolytic drugs: the influence of migratory behaviour of endothelial cells. Biomed. Biochim. Acta 43, 447-456.
54. Tsopanoglou, N. E., Pipili-Synetos, E. and Maragoudakis, M. E. (1993). Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol. 265, C1302-1307.
55. Vlodavsky, I., Folkman, J., Sullivan, R., Fridman, R., Ishai-Michaeli, R., Sasse, J. and Klagsbrun, M. (1987). Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc. Nat. Acad. Sci. USA 84, 2292-2296.
56. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V. and Underwood, P. A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanase. J. Biol. Chem. 271, 10079-10086.
57. Yasunaga, C., Nakashima, Y. and Sueishi, K. (1989). A role of fibrinolytic activity in angiogenesis. Quantitative assay using in vitro method. Lab. Invest. 61, 698-704.
58. Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., Vincenti, V., Granger, H. J., Viglietto, G. and Persico, M. G. (1997). Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab. Invest. 76, 517-531.